Sep. 12 at 10:24 PM
$GANX The interview also has a transcript
Watch "This CEO is Fighting Parkinson’s & Other Neuro-Degenerative Diseases. Gene Mack - Gain Therapeutics" on YouTube
https://youtu.be/exCO7jGwmZE?is=Zn9qhNa82IU7oyBO
What we're trying to do with gain is create a new backbone of therapy disease modifying so that if we can't totally stop the progression of Parkinson's in certain patients, hopefully the symptomatic relief lasts longer and is more effective along the help it's getting from disease modifying drugs such as Rexeract, which is our lead drug candidate.
Now, these are neurons that are viable but in distress and they're sending out signals of this distress and they're saying, "Hey, we're in trouble uh and and and we need help."
What we're trying to do is maybe restore the attack, you know, restore the neurons that are that are distressed and under attack and preserve that tissue and potentially give patients a chance to regain some function over time
